Yubo International Biotech Limited (YBGJ)
Yubo International Biotech Limited operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Beijing, BE, CN. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $2.0M. On trailing twelve-month figures it carries a trailing P/E of -1.72, a net margin of -681.8%. Its beta of 0.71 implies it has historically moved less than the broad market.
Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand. The company's headquarters are located in Beijing, China.
Yubo International Biotech Limited is most often compared with the following Healthcare names: